STAT15d
Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
Hosted on MSN15d
FDA CDER director Patrizia Cavazzoni announces resignation
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
Patrizia Cavazzoni, key FDA official, to leave agency
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is one of several announced by high-ranking FDA leaders ahead of the coming ...
Investor's Business Daily on MSN9d
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...
Becker's Hospital Review16d
FDA drug evaluation leader to exit
The director of the FDA's Center for Drug Evaluation and Research, Patrizia Cavazzoni, MD, will step down from the role Jan. 18, according to an Endpoints News report. Dr. Cavazzoni joined the FDA ...
HHS Secretary Becerra urges Trump administration to 'continue to grow' the ACA
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
pharmaphorum4d
FDA launches innovation hub to spur rare disease R&D
It will be co-led by Patrizia Cavazzoni, director of the FDA's Centre for Drugs Evaluation and Research (CDER), and Centre for Biologics Evaluation and Research (CBER) director Peter Marks.
Las Vegas Sun13d
Alternative remedies prescribed as FDA weighs whether to pull plug on drug
Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...